JPH07194395A - Reagent for measuring inorganic phosphorus - Google Patents

Reagent for measuring inorganic phosphorus

Info

Publication number
JPH07194395A
JPH07194395A JP35033293A JP35033293A JPH07194395A JP H07194395 A JPH07194395 A JP H07194395A JP 35033293 A JP35033293 A JP 35033293A JP 35033293 A JP35033293 A JP 35033293A JP H07194395 A JPH07194395 A JP H07194395A
Authority
JP
Japan
Prior art keywords
reagent
inorganic phosphorus
inosine
measuring
xod
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP35033293A
Other languages
Japanese (ja)
Other versions
JP3434553B2 (en
Inventor
Takayuki Fujii
隆行 藤井
Hozumi Tsuchiya
ほずみ 土屋
Masami Kojima
正美 小島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iatron Laboratories Inc
Mitsubishi Kagaku Iatron Inc
Original Assignee
Iatron Laboratories Inc
Mitsubishi Kagaku Iatron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iatron Laboratories Inc, Mitsubishi Kagaku Iatron Inc filed Critical Iatron Laboratories Inc
Priority to JP35033293A priority Critical patent/JP3434553B2/en
Publication of JPH07194395A publication Critical patent/JPH07194395A/en
Application granted granted Critical
Publication of JP3434553B2 publication Critical patent/JP3434553B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To obtain a reagent for measuring inorganic phosphorus useful for an automatic analyzer, etc., having stability for a long period of time, not requiring dissolution operation, comprising a first reagent containing xanthine oxidase, purine nucleoside phosphorylase, etc., and a second reagent containing inosine, etc. CONSTITUTION:This reagent for measuring inorganic phosphorus is obtained by blending a first reagent containing at least xanthine oxidase and purine nucleoside phosphorylase with a second reagent containing at least inosine and, further, peroxidase, 4-aminoantipyrine and N-ethyl-N-sulfopropyl-m-toluidine each in a liquid reagent, respectively. By using the reagent, inorganic phosphorus in the specimen is reacted with inosine in the presence of purine nucleoside phosphorylase, formed hypoxanthine is treated with hypoxanthine oxidase, formed H2O2 reacted with 4-aminoantipyrine and N-ethyl-N-sulfopropyl-m- toluidine and a formed quinoid coloring matter is measured to determine inorganic phosphorus.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、無機リン測定用試薬に
関する。更に詳細には、長期間安定な無機リン測定用の
液状化された試薬組成物に関する。
TECHNICAL FIELD The present invention relates to a reagent for measuring inorganic phosphorus. More specifically, it relates to a liquefied reagent composition for long-term stable inorganic phosphorus measurement.

【0002】[0002]

【従来の技術】人体のリン(無機リン又は有機リン)
は、骨を形成し、高エネルギーリン酸化化合物、核酸又
はリン脂質などを構成する他、血液の緩衝能保持にも貢
献している。無機リンは、各種ホルモンやビタミンDに
よる代謝調節を受けており、カルシウムと共に電解質代
謝の動態を知る上で血中又は尿中濃度の測定が重要であ
る。臨床的には腎機能や骨代謝をよく反映し、特に尿中
排泄が低下する慢性腎不全では著しい高リン症が見られ
る。
2. Description of the Related Art Phosphorus of human body (inorganic phosphorus or organic phosphorus)
Forms bone, constitutes a high-energy phosphorylated compound, a nucleic acid, a phospholipid, and the like, and also contributes to retaining the buffering capacity of blood. Inorganic phosphorus is metabolically regulated by various hormones and vitamin D, and it is important to measure the concentration in blood or urine in order to know the dynamics of electrolyte metabolism together with calcium. Clinically, renal hyperfunction and bone metabolism are well reflected, and marked hyperphosphatemia is seen especially in chronic renal failure with decreased urinary excretion.

【0003】無機リン測定法としては従来から種々の方
法が確立されており、それぞれの特徴をもっている。例
えば、検体中の無機リンを酸性溶液中でモリブデン酸ア
ンモニウムと反応させ、生成するリンモリブデン酸アン
モニウムを比色測定して無機リン量を求める方法や、リ
ンモリブデン酸アンモニウムを更に還元処理してモリブ
デンブルーにし、これを比色測定して無機リン量を求め
る方法などがあった。しかし、これらの方法には、操作
の煩雑さ、低感度、機器の着色や腐食など種々の問題も
ある。
Various inorganic phosphorus measuring methods have been established and have their respective characteristics. For example, a method in which inorganic phosphorus in a sample is reacted with ammonium molybdate in an acidic solution, and the resulting ammonium phosphomolybdate is colorimetrically measured to obtain the amount of inorganic phosphorus, or ammonium phosphomolybdate is further reduced to give molybdenum. There was a method of obtaining an amount of inorganic phosphorus by making it blue and measuring this colorimetrically. However, these methods have various problems such as complexity of operation, low sensitivity, coloring and corrosion of equipment.

【0004】そこで、近年は以下の工程からなる測定方
法がよく用いられている。すなわち、検体中の無機リン
に、イノシンの存在下でプリンヌクレオシドホスフォリ
ラーゼ(以下PNPと略す)及びキサンチンオキシダー
ゼ(以下XODと略す)を作用させてH22 を生成さ
せ、続いてこのH22 をペルオキシダーゼ(以下PO
Dと略す)の存在下で、カプラーとしての4−アミノア
ンチピリン(以下4AAPと略す)と水素供与体として
のN−エチル−N−スルホプロピル−m−トルイジン
(以下ESPTと略す))、N−エチル−N−(2−ヒ
ドロキシ−3−スルホプロピル)3,5−ジメトキシア
ニリン(以下DAOSと略す)又はN−(2−ヒドロキ
シ−3−スルホプロピル)3,5−ジメトキシアニリン
(以下HDAOSと略す)などと酸化縮合反応させてキ
ノイド色素を形成させ、得られた色素を比色測定して無
機リン量を求める方法である。この測定法は再現性及び
直線性に優れており、機器の着色や腐食の心配もないの
で繁用されている。
Therefore, in recent years, a measuring method consisting of the following steps is often used. That is, purine nucleoside phosphorylase (hereinafter abbreviated as PNP) and xanthine oxidase (hereinafter abbreviated as XOD) are caused to act on inorganic phosphorus in a sample in the presence of inosine to generate H 2 O 2 , and then this H 2 2 O 2 peroxidase (hereinafter PO
In the presence of D), 4-aminoantipyrine (hereinafter abbreviated as 4AAP) as a coupler and N-ethyl-N-sulfopropyl-m-toluidine (hereinafter abbreviated as ESPT) as a hydrogen donor), N- Ethyl-N- (2-hydroxy-3-sulfopropyl) 3,5-dimethoxyaniline (abbreviated as DAOS hereinafter) or N- (2-hydroxy-3-sulfopropyl) 3,5-dimethoxyaniline (abbreviated as HDAOS hereinafter) ) And the like to form a quinoid pigment by an oxidative condensation reaction, and the pigment obtained is colorimetrically measured to determine the amount of inorganic phosphorus. This measurement method is widely used because it has excellent reproducibility and linearity, and there is no concern about coloring or corrosion of equipment.

【0005】[0005]

【発明が解決しようとする課題】しかし、前記のキノイ
ド色素を形成させる方法では不安定なPNPやXODな
どの酵素が用いられており、液状での長期保存が難しい
ので、試薬形態を凍結乾燥品として供給されていた。ま
た、各成分の安定条件もそれぞれ異なるため、試薬を構
成する場合、それら試薬の安定性は各成分の組み合わせ
により大きく変化し、特に液状試薬の場合、通常の組み
合わせでは長期間安定性を維持するのが困難であった。
However, in the above-mentioned method for forming a quinoid pigment, an unstable enzyme such as PNP or XOD is used, and it is difficult to store it in a liquid state for a long time. Was supplied as. In addition, since the stability conditions of each component also differ, the stability of the reagents when they are made up greatly changes depending on the combination of each component, and in the case of a liquid reagent in particular, the ordinary combination maintains stability for a long period of time. Was difficult.

【0006】一方、自動分析機の普及に伴って、無機リ
ン測定法の試薬構成も1試薬系から2試薬系に代わって
きている。2試薬系での試薬組成の従来の組み合わせ
は、第一試薬がXOD、POD、ESPT及びイノシン
からなり、第二試薬がPNPと4AAPとからなる構成
や、あるいは第一試薬がXOD、POD及びESPTか
らなり、第二試薬がイノシン、PNP及び4AAPとか
らなるように構成されていたが、液状での保存安定性は
極めて乏しいものであった。更に、近年、使用時に試薬
を液状に調製するのではなく、供給時の試薬形態から液
状とし、ユーザーの作業性を向上させることが求められ
ている。
On the other hand, with the spread of automatic analyzers, the reagent composition of the inorganic phosphorus measuring method has been changed from the one-reagent system to the two-reagent system. A conventional combination of reagent compositions in a two-reagent system is such that the first reagent is composed of XOD, POD, ESPT and inosine and the second reagent is composed of PNP and 4AAP, or the first reagent is composed of XOD, POD and ESPT. The second reagent was composed of inosine, PNP and 4AAP, but the storage stability in liquid form was extremely poor. Further, in recent years, it has been required to improve the workability of the user by preparing a reagent from a liquid form at the time of supply, rather than preparing the reagent in a liquid form at the time of use.

【0007】本発明者らは、こうした従来の問題を解決
すべく鋭意研究を重ねた結果、液状試薬の形態で供給し
ても、長期間にわたって充分な保存安定性を有する試薬
組成を見出した。更に、この試薬組成における酵素の安
定化についても検討した結果、好適な安定化剤を見出す
ことに成功した。本発明はこうした知見に基づくもので
ある。
As a result of intensive studies to solve such conventional problems, the present inventors have found a reagent composition having sufficient storage stability for a long period of time even when supplied in the form of a liquid reagent. Furthermore, as a result of investigating the stabilization of the enzyme in this reagent composition, we succeeded in finding a suitable stabilizer. The present invention is based on these findings.

【0008】[0008]

【課題を解決するための手段】本発明は、プリンヌクレ
オシドホスフォリラーゼ、キサンチンオキシダーゼ、ペ
ルオキシダーゼ、イノシン、4−アミノアンチピリン及
びN−エチル−N−スルホプロピル−m−トルイジンを
含む無機リン測定用試薬において、少なくともキサンチ
ンオキシダーゼ及びプリンヌクレオシドホスフォリラー
ゼを含有する第一試薬と、少なくともイノシンを含有す
る第二試薬とからなり、それぞれが液状試薬であること
を特徴とする、無機リン測定用試薬に関する。
The present invention provides a reagent for measuring inorganic phosphorus containing purine nucleoside phosphorylase, xanthine oxidase, peroxidase, inosine, 4-aminoantipyrine and N-ethyl-N-sulfopropyl-m-toluidine. 2. A reagent for measuring inorganic phosphorus, comprising a first reagent containing at least xanthine oxidase and purine nucleoside phosphorylase, and a second reagent containing at least inosine, each being a liquid reagent.

【0009】以下、本発明を詳細に説明する。本発明に
よる無機リン測定用試薬を適用することのできる測定方
法は、検体中の無機リンにプリンヌクレオシドホスフォ
リラーゼ(PNP)の存在下でイノシンを反応させてヒ
ポキサンチンを生成させ、得られたヒポキサンチンにキ
サンチンオキシダーゼ(XOD)を作用させて過酸化水
素を生成させ、得られた過酸化水素にペルオキシダーゼ
(POD)の存在下で4−アミノアンチピリン(4AA
P=カプラー)及びN−エチル−N−スルホプロピル−
m−トルイジン(ESPT=水素供与体)を反応させて
キノイド色素を形成させ、こうして形成されるキノイド
色素の増加量を測定することからなる。この測定方法を
反応式で示せば、以下のとおりである。
The present invention will be described in detail below. The measurement method to which the reagent for measuring inorganic phosphorus according to the present invention can be applied is obtained by reacting inosine with inorganic phosphorus in a sample in the presence of purine nucleoside phosphorylase (PNP) to produce hypoxanthine. Xanthine oxidase (XOD) is allowed to act on hypoxanthine to generate hydrogen peroxide, and the resulting hydrogen peroxide is treated with 4-aminoantipyrine (4AA) in the presence of peroxidase (POD).
P = coupler) and N-ethyl-N-sulfopropyl-
It consists of reacting m-toluidine (ESPT = hydrogen donor) to form a quinoid dye and measuring the increased amount of the quinoid dye thus formed. This measuring method can be represented by a reaction formula as follows.

【0010】 [0010]

【0011】前記の反応工程からなる無機リン測定方法
に用いる本発明の無機リン測定用試薬は、(1)少なく
ともXODとPNPとを含む液状第一試薬と、(2)少
なくともイノシンを含む液状第二試薬とから構成され
る。イノシンとPNPとを共存させると、これらが保存
中に反応してしまい、無機リンの測定に大きな影響を与
える(キサンチン様物質が生成するためと考えられ
る)。この影響を回避するために両者を分ける必要があ
る。
The reagent for measuring inorganic phosphorus of the present invention used in the method for measuring inorganic phosphorus comprising the above-mentioned reaction steps comprises (1) a liquid first reagent containing at least XOD and PNP, and (2) a liquid first reagent containing at least inosine. It consists of two reagents. When inosine and PNP coexist, these react with each other during storage and have a great influence on the measurement of inorganic phosphorus (probably because a xanthine-like substance is produced). It is necessary to separate the two in order to avoid this effect.

【0012】更に、これらの第一試薬と第二試薬とを用
いて無機リンを測定する場合には、検体中の内因性キサ
ンチンを予め消去しておくことが好ましい。このため、
最初に検体と接触させる第一試薬にXODを含ませてお
くと共に、第一試薬には更にESPTを添加するか、あ
るいは、第一試薬に更にカタラーゼを添加するのが好ま
しい。後者の場合には、ESPTを第二試薬に添加す
る。また、第一試薬にESPTとカタラーゼとを添加
し、第二試薬にPODを添加してもよい。すなわち、X
ODを含有する第一試薬を検体と接触させると、このX
ODが内因性キサンチンに作用してH22 が生成され
る。第一試薬内に、更にESPTが存在すると、ESP
Tによる自己縮合反応によりH22 が消去される。ま
た、第一試薬内にカタラーゼが存在すると、カタラーゼ
による消去反応によりH22 が消去される。こうして
内因性キサンチンによる影響をなくした後で、イノシン
を含有する第二試薬を検体に接触させると、測定対象物
である無機リンがイノシンの存在下でPNP及びXOD
の作用によりH22 を生成し、このH22 がPOD
の存在下でカプラーと水素供与体を酸化縮合反応してキ
ノイド色素を形成させる。この際に、イノシンとPNP
との共存を避けるために、PNPを第一試薬に添加する
のが好ましい。
Further, when the inorganic phosphorus is measured using these first reagent and second reagent, it is preferable to eliminate the endogenous xanthine in the sample in advance. For this reason,
It is preferable to add XOD to the first reagent that first comes into contact with the sample, and further add ESPT to the first reagent or further add catalase to the first reagent. In the latter case, ESPT is added to the second reagent. Further, ESPT and catalase may be added to the first reagent and POD may be added to the second reagent. That is, X
When the first reagent containing OD is brought into contact with the sample, the X
OD acts on endogenous xanthine to produce H 2 O 2 . If ESPT is further present in the first reagent, ESP
The self-condensation reaction by T erases H 2 O 2 . When catalase is present in the first reagent, H 2 O 2 is erased by the elimination reaction by catalase. When the second reagent containing inosine is brought into contact with the sample after eliminating the influence of the endogenous xanthine in this way, the inorganic phosphorus, which is the measurement target, is present in the presence of inosine as PNP and XOD.
Generates H 2 O 2 by the action, the H 2 O 2 is POD
The coupler and the hydrogen donor are subjected to oxidative condensation reaction in the presence of to form a quinoid dye. At this time, inosine and PNP
It is preferred to add PNP to the first reagent to avoid coexistence with.

【0013】従って、第一試薬がXOD、PNP及びP
ODを含有し、第二試薬がイノシン及び4AAPを含有
し、更に、内因性キサンチンを予め消去するために、上
記第一試薬にESPTを添加(自己縮合反応による消
去)するか、あるいは上記第一試薬にカタラーゼを添加
し、第二試薬にESPTを添加(カタラーゼによる消去
反応)した試薬構成とすることが好適である。なお、上
記の反応工程に参加するH2 OとO2 は、検体から供給
される。
Therefore, the first reagent is XOD, PNP and P.
OD is contained, the second reagent contains inosine and 4AAP, and ESPT is added to the first reagent (elimination by self-condensation reaction) in order to eliminate the endogenous xanthine in advance. It is preferable to have a reagent configuration in which catalase is added to the reagent and ESPT is added to the second reagent (elimination reaction by catalase). The H 2 O and O 2 that participate in the above reaction step are supplied from the sample.

【0014】第一試薬に含まれるXODの由来について
は特に限定されないが、微生物由来のXODが好適に用
いられる。その添加量は個々の具体的測定系を考慮して
適宜選択することができるが、一般的に1〜100U/
ml、好ましくは5〜50U/mlであれば良い。1U
/ml未満になると充分な酵素活性が得られない。10
0U/mlを超えても測定上の支障はないが、不純物混
入の問題やコストの面からは必ずしも有利ではなく、必
要以上の過剰量を添加する必要はない。
The origin of XOD contained in the first reagent is not particularly limited, but a microorganism-derived XOD is preferably used. The addition amount can be appropriately selected in consideration of each specific measurement system, but is generally 1 to 100 U /
ml, preferably 5 to 50 U / ml. 1U
If it is less than / ml, sufficient enzyme activity cannot be obtained. 10
There is no problem in measurement even if it exceeds 0 U / ml, but it is not necessarily advantageous in view of the problem of contamination of impurities and cost, and it is not necessary to add an excessive amount more than necessary.

【0015】PNPについてもその由来は特に限定され
ず、動物組織、赤血球又は酵母由来のPNPを用いるこ
とができる。その添加量は個々の具体的測定系を考慮し
て適宜選択することができるが、一般的に0.1〜10
U/ml、好ましくは0.5〜5U/mlであれば良
い。0.1U/ml未満になると充分な酵素活性が得ら
れない。10U/mlを超えても測定上の支障はない
が、不純物混入の問題やコストの面からは必ずしも有利
ではなく、必要以上の過剰量を添加する必要はない。
The origin of PNP is not particularly limited, and PNP derived from animal tissue, erythrocyte or yeast can be used. The addition amount can be appropriately selected in consideration of each specific measurement system, but is generally 0.1 to 10
U / ml, preferably 0.5 to 5 U / ml. If it is less than 0.1 U / ml, sufficient enzyme activity cannot be obtained. There is no problem in measurement even if it exceeds 10 U / ml, but it is not necessarily advantageous from the viewpoint of the problem of mixing impurities and the cost, and it is not necessary to add an excessive amount more than necessary.

【0016】PODについてもその由来は特に限定され
ず、動物組織や西洋わさび由来のPODを用いることが
できる。その添加量は個々の具体的測定系を考慮して適
宜選択することができるが、一般的に1〜100U/m
l、好ましくは5〜50U/mlであれば良い。1U/
ml未満になると充分な酵素活性が得られない。100
U/mlを超えても測定上の支障はないが、不純物混入
の問題やコストの面からは必ずしも有利ではなく、必要
以上の過剰量を添加する必要はない。
The origin of POD is not particularly limited, and POD derived from animal tissue or horseradish can be used. The addition amount can be appropriately selected in consideration of the individual specific measurement system, but is generally 1 to 100 U / m.
1, preferably 5 to 50 U / ml. 1U /
If it is less than ml, sufficient enzyme activity cannot be obtained. 100
Even if it exceeds U / ml, there is no problem in measurement, but it is not necessarily advantageous in terms of the problem of contamination of impurities and the cost, and it is not necessary to add an excessive amount more than necessary.

【0017】第二試薬に含まれるイノシンの添加量も、
個々の具体的測定系を考慮して適宜選択することができ
るが、一般的に0.5〜50mM、好ましくは1〜10
mMであれば良い。0.5mM未満になると充分な酵素
反応が起こらない。50mMを超えても測定上の支障は
ないが、不純物混入の問題やコストの面、更には基質障
害の発生から必ずしも有利ではなく、必要以上の過剰量
を添加する必要はない。
The addition amount of inosine contained in the second reagent is also
Although it can be appropriately selected in consideration of the individual specific measurement system, it is generally 0.5 to 50 mM, preferably 1 to 10
It may be mM. If it is less than 0.5 mM, a sufficient enzymatic reaction does not occur. Although there is no problem in measurement even if it exceeds 50 mM, it is not necessarily advantageous in terms of problems of contamination of impurities and cost, and further, substrate damage occurs, and it is not necessary to add an excessive amount more than necessary.

【0018】4AAPについても、その添加量は個々の
具体的測定系を考慮して適宜選択することができるが、
一般的に0.1〜20mM、好ましくは0.5〜10m
Mであれば良い。0.1mM未満になると充分な酵素反
応が起こらない。20mMを超えても測定上の支障はな
いが、不純物混入の問題やコストの面から必ずしも有利
ではなく、必要以上の過剰量を添加する必要はない。
The amount of 4AAP added can be appropriately selected in consideration of each specific measurement system.
Generally 0.1 to 20 mM, preferably 0.5 to 10 m
It is good if it is M. If it is less than 0.1 mM, a sufficient enzymatic reaction does not occur. Although there is no problem in measurement even if it exceeds 20 mM, it is not necessarily advantageous in view of the problem of mixing impurities and the cost, and it is not necessary to add an excessive amount more than necessary.

【0019】また、緩衝液及びそのpHは、第一試薬及
び第二試薬共に、XOD、PNP及びPODの反応至適
pHで、保存安定性のよいpH5.0〜pH9.0、特
にpH6.0〜pH8.0が好ましく、このpHで緩衝
能のある緩衝液を用いるのが好ましい。具体的にはPI
PES〔ピペラジン−N’,N’−ビス(2−エタンス
ルホン酸)〕、BES〔N,N−ビス(2−ヒドロキシ
エチル)−2−アミノエタンスルホン酸〕、HEPES
〔N−2−ヒドロキシエチルピペラジン−N’−2−エ
タンスルホン酸〕などのグッド緩衝液を使用することが
できる。この他、前記pH範囲で緩衝能のある緩衝液
で、反応性や安定性などに問題がないものであれば、何
を用いてもよい。
The buffer solution and its pH are both optimum for the reaction of XOD, PNP and POD with both the first reagent and the second reagent, and have good storage stability at pH 5.0 to pH 9.0, especially pH 6.0. -PH 8.0 is preferable, and it is preferable to use a buffer solution having a buffering capacity at this pH. Specifically, PI
PES [piperazine-N ', N'-bis (2-ethanesulfonic acid)], BES [N, N-bis (2-hydroxyethyl) -2-aminoethanesulfonic acid], HEPES
Good buffer solutions such as [N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid] can be used. In addition, any buffer solution having a buffering ability in the above pH range may be used as long as it has no problem in reactivity or stability.

【0020】検体中の内因性キサンチンを予め消去する
ために、第一試薬にESPTを添加する場合、その添加
量は個々の具体的測定系を考慮して適宜選択することが
できるが、一般的に0.5〜50mM、好ましくは1〜
10mMであれば良い。0.1mM未満になると充分な
酵素反応が起こらない。20mMを超えても測定上の支
障はないが、不純物混入の問題やコストの面から必ずし
も有利ではなく、必要以上の過剰量を添加する必要はな
い。
When ESPT is added to the first reagent in order to eliminate the endogenous xanthine in the sample in advance, the addition amount thereof can be appropriately selected in consideration of each specific measurement system. 0.5 to 50 mM, preferably 1 to
It may be 10 mM. If it is less than 0.1 mM, a sufficient enzymatic reaction does not occur. Although there is no problem in measurement even if it exceeds 20 mM, it is not necessarily advantageous in view of the problem of mixing impurities and the cost, and it is not necessary to add an excessive amount more than necessary.

【0021】また、第一試薬にカタラーゼを添加し、第
二試薬にESPTを添加する場合、ESPTは第一試薬
に添加する場合と同様の条件で第二試薬に添加すれば良
い。一方、カタラーゼについてはその由来は特に限定さ
れず、動物や細菌由来のカタラーゼを用いることができ
る。その添加量は個々の具体的測定系を考慮して適宜選
択することができるが、一般的に1〜100U/ml、
好ましくは5〜50U/mlであれば良い。1U/ml
未満になると充分な酵素活性が得られない。100U/
mlを超えても測定上の支障はないが、不純物混入の問
題やコストの面からは必ずしも有利ではなく、必要以上
の過剰量を添加する必要はない。
When catalase is added to the first reagent and ESPT is added to the second reagent, ESPT may be added to the second reagent under the same conditions as when adding ESPT to the first reagent. On the other hand, the origin of catalase is not particularly limited, and catalase derived from animals or bacteria can be used. The addition amount can be appropriately selected in consideration of each specific measurement system, but generally 1 to 100 U / ml,
It is preferably 5 to 50 U / ml. 1 U / ml
If it is less than this, sufficient enzyme activity cannot be obtained. 100 U /
Although there is no problem in measurement even if it exceeds ml, it is not necessarily advantageous from the viewpoint of the problem of mixing impurities and the cost, and it is not necessary to add an excessive amount more than necessary.

【0022】上述のように構成された本発明による無機
リン測定用液状試薬は、上記の態様で充分に長期間安定
性を維持することができるが、本発明者は更に、微生物
由来のXODについてその安定化方法を検討したとこ
ろ、オキソン酸又はその塩、あるいはエチレンジアミン
四酢酸二ナトリウム(EDTA2Na)などのキレ−ト
剤、あるいはエチレンジアミン四酢酸亜鉛錯体(EDT
A−Zn)などの金属−キレート化合物を含有させるこ
とにより、XODを安定化することができることを見出
した。
The liquid reagent for measuring inorganic phosphorus according to the present invention having the above-mentioned structure can maintain stability for a sufficiently long period in the above-mentioned mode. When the stabilization method was examined, oxo acid or its salt, a chelating agent such as ethylenediaminetetraacetic acid disodium (EDTA2Na), or an ethylenediaminetetraacetic acid zinc complex (EDT).
It has been found that the inclusion of a metal-chelate compound such as A-Zn) can stabilize XOD.

【0023】従来技術においても、例えば、特開平4−
335887号公報にはXODを安定化させる方法が開
示されている。すなわち、鉄、銅、コバルト及びマンガ
ンからなる群より選ばれた金属の塩(錯塩を含む)及び
/又はこれらの金属キレート化合物によりXODが安定
化されることが記載されている。しかし、この方法は、
バターミルク由来のXODを使用した場合の安定化方法
であり、微生物由来XODの安定化条件とは異なる。こ
れに対して、微生物由来のXODでは、鉄、銅、コバル
ト及びマンガンからなる群より選ばれた金属の金属キレ
ート化合物以外にも、亜鉛、マグネシウム及びカルシウ
ムからなる群より選ばれた金属の金属キレート化合物に
より、好適な安定化効果を得ることができる。
Also in the prior art, for example, Japanese Unexamined Patent Publication No.
Japanese Patent No. 335887 discloses a method for stabilizing XOD. That is, it is described that XOD is stabilized by a salt of a metal (including a complex salt) selected from the group consisting of iron, copper, cobalt and manganese and / or a metal chelate compound thereof. But this method
This is a stabilization method using XOD derived from buttermilk, which is different from the stabilization conditions for XOD derived from microorganisms. On the other hand, in the XOD derived from microorganisms, in addition to the metal chelate compound of the metal selected from the group consisting of iron, copper, cobalt and manganese, the metal chelate of the metal selected from the group consisting of zinc, magnesium and calcium. Depending on the compound, a suitable stabilizing effect can be obtained.

【0024】本発明で微生物由来XODを使用する場合
には、その安定化剤として、具体的には、オキソン酸;
オキソン酸塩、例えば、オキソン酸カリウム又はオキソ
ン酸アンモニウム;キレート剤、例えば、エチレンジア
ミン四酢酸(EDTA)、1,2−シクロヘキサンジア
ミン四酢酸(CyDTA)、サルコシン二アンモニウム
塩(DTCS)、ニトリロ三プロピオン酸(NTP)、
イミノ二酢酸(IDA)、若しくはニトリロ三酢酸(N
TA)又はこれらの塩、例えば、エチレンジアミン四酢
酸二ナトリウム(EDTA2Na)やニトリロ三酢酸二
ナトリウム塩(NTA2Na);又は金属−キレート化
合物(すなわち、前述のキレート剤と鉄、銅、コバル
ト、マンガン、亜鉛、マグネシウム及びカルシウムから
なる群より選ばれた金属との化合物)、例えば、エチレ
ンジアミン四酢酸亜鉛錯体(EDTA−Zn)、1,2
−シクロヘキサンジアミン四酢酸カルシウム錯体(Cy
DTA−Ca)などを、単独で又は組み合わせて用いる
ことができる。
When the microorganism-derived XOD is used in the present invention, its stabilizing agent is specifically oxo acid;
Oxonates, such as potassium oxonate or ammonium oxonate; chelating agents, such as ethylenediaminetetraacetic acid (EDTA), 1,2-cyclohexanediaminetetraacetic acid (CyDTA), sarcosine diammonium salt (DTCS), nitrilotripropionic acid. (NTP),
Iminodiacetic acid (IDA) or nitrilotriacetic acid (N
TA) or salts thereof, such as disodium ethylenediaminetetraacetate (EDTA2Na) and disodium nitrilotriacetate (NTA2Na); or metal-chelating compounds (ie, the above chelating agents and iron, copper, cobalt, manganese, zinc). , A compound with a metal selected from the group consisting of magnesium and calcium), for example, ethylenediaminetetraacetic acid zinc complex (EDTA-Zn), 1,2
-Cyclohexanediaminetetraacetic acid calcium complex (Cy
DTA-Ca) and the like can be used alone or in combination.

【0025】これらXOD安定化剤の添加量は、個々の
具体的測定系を考慮して適宜選択することができるが、
一般的に0.1〜100mM、好ましくは0.2〜20
mMであれば良い。0.1mM未満になると充分な安定
化効果を得ることができない。100mMを超えても安
定化効果の上では支障はないが、不純物混入の問題やコ
ストの面から必ずしも有利ではなく、必要以上の過剰量
を添加する必要はない。なお、バターミルク由来のXO
Dは不安定な酵素であり、前記特開平4−335887
号公報記載のXOD安定化方法を用いても、長期保存可
能な液状試薬を完成するために必要な安定性を得ること
はできない。
The amount of these XOD stabilizers added can be appropriately selected in consideration of each specific measurement system.
Generally 0.1-100 mM, preferably 0.2-20
It may be mM. If it is less than 0.1 mM, a sufficient stabilizing effect cannot be obtained. Even if it exceeds 100 mM, it does not hinder the stabilizing effect, but it is not necessarily advantageous in view of the problem of mixing impurities and the cost, and it is not necessary to add an excessive amount more than necessary. XO derived from buttermilk
D is an unstable enzyme, and is described in JP-A-4-335887.
Even if the XOD stabilization method described in the publication is used, it is not possible to obtain the stability required to complete a liquid reagent that can be stored for a long period of time.

【0026】PNPについても同様に安定化方法を検討
したところ、微生物由来PNPに対しては、ウシ血清ア
ルブミン(BSA)を安定化剤として用いることができ
る。このPNP安定化剤の添加量も、個々の具体的測定
系を考慮して適宜選択することができるが、一般的に
0.1〜100g/リットル、好ましくは1〜10g/
リットルであれば良い。0.1g/リットル未満になる
と充分な安定化効果を得ることができない。100g/
リットルを超えても安定化効果の上では支障はないが、
不純物混入の問題やコストの面から必ずしも有利ではな
く、必要以上の過剰量を添加する必要はない。
When the stabilization method was similarly examined for PNP, bovine serum albumin (BSA) can be used as a stabilizer for microbial PNP. The amount of the PNP stabilizer added can be appropriately selected in consideration of the individual specific measurement system, but is generally 0.1 to 100 g / liter, preferably 1 to 10 g / liter.
It should be liters. If it is less than 0.1 g / liter, a sufficient stabilizing effect cannot be obtained. 100 g /
Even if it exceeds liter, there is no problem in stabilizing effect,
It is not always advantageous in terms of the problem of mixing impurities and the cost, and it is not necessary to add an excessive amount more than necessary.

【0027】第一試薬及び/又は第二試薬には、前記の
各成分の他に、NaN3 などの防腐剤やPODの安定化
剤(例えば、アスコルビン酸オキシダーゼなど)を適宜
添加することができる。
In addition to the above-mentioned components, a preservative such as NaN 3 and a stabilizer for POD (for example, ascorbate oxidase) can be appropriately added to the first reagent and / or the second reagent. .

【0028】[0028]

【作用】このように構成された本発明による無機リン測
定用試薬により、検体中の無機リンから、イノシンの存
在下でPNP及びXODの作用によりH22 を生成さ
せ、このH22 をPODの存在下で4AAPとESP
Tとにより酸化縮合反応させて、キノイド色素を形成さ
せる。この色素を比色測定して無機リン量を求めること
ができる。更に、本発明の液状試薬は、長期間保存可能
で、臨床検査分野での取扱いが極めて容易になる。
With the above-configured reagent for measuring inorganic phosphorus according to the present invention, H 2 O 2 is produced from the inorganic phosphorus in the sample by the action of PNP and XOD in the presence of inosine, and this H 2 O 2 is produced. 4AAP and ESP in the presence of POD
An oxidative condensation reaction is performed with T to form a quinoid pigment. The amount of inorganic phosphorus can be determined by colorimetrically measuring this dye. Furthermore, the liquid reagent of the present invention can be stored for a long period of time, and is extremely easy to handle in the clinical laboratory field.

【0029】[0029]

【実施例】以下、実施例によって本発明を具体的に説明
するが、これらは本発明の範囲を限定するものではな
い。実施例1 (1)試薬の調製 以下の組成からなる、本発明の第一試薬A〜D及び第二
試薬Aを調製した。 第一試薬A:50mM PIPES緩衝液(pH6.
8) XOD 16U/ml PNP 2U/ml POD 10U/ml ESPT 5mM 第一試薬B:第一試薬AにBSAを2mg/mlとなる
ように添加したもの。 第一試薬C:第一試薬Aにオキソン酸カリウム5mM、
EDTA−Znを0.5mMとなるように添加したも
の。 第一試薬D:第一試薬AにBSAを2mg/ml、オキ
ソン酸カリウム5mM、EDTA−Znを0.5mMと
なるように添加したもの。 第二試薬A:50mM PIPES緩衝液(pH6.
8) イノシン 3.7mM 4AAP 1mM
The present invention will be described in detail below with reference to examples, but these do not limit the scope of the present invention. Example 1 (1) Preparation of Reagents First reagents A to D and second reagent A of the present invention having the following compositions were prepared. First reagent A: 50 mM PIPES buffer (pH 6.
8) XOD 16 U / ml PNP 2 U / ml POD 10 U / ml ESPT 5 mM First reagent B: BSA added to the first reagent A at 2 mg / ml. First reagent C: potassium oxonate 5 mM in the first reagent A,
EDTA-Zn added at 0.5 mM. First reagent D: BSA added to the first reagent A at 2 mg / ml, potassium oxonate 5 mM, and EDTA-Zn at 0.5 mM. Second reagent A: 50 mM PIPES buffer (pH 6.
8) Inosine 3.7 mM 4AAP 1 mM

【0030】(2)安定性試験操作 上記の組み合わせにおいて、無機リン含量既知の管理血
清5μlに各第一試薬A〜D0.2mlを添加し、37
℃にて5分間加温した。次いで、第二試薬A0.2ml
を添加して、37℃で5分間反応させ、該反応液につい
て波長600nmにおける吸光度を測定した。同時に、
血清に代えて生理食塩水を用いて同様の操作を行い、そ
の時の値をブランク値とした。更に別に、標準としてリ
ン酸一カリウムの水溶液(5mg/ml)を調製して同
様の操作を行い管理血清中の無機リン量を求めた。ま
た、各試薬を10℃にて保存し、2ヶ月後、4ヶ月後、
6ヶ月後、9ヶ月後及び12ヶ月後に前記と同様の管理
血清を用いて同様の操作を行い無機リン量を求めた。こ
の時の標準は調製直後に測定した際の吸光度を用いて計
算した。得られた結果を図1に示す。本発明の試薬(第
一試薬A〜Dと第二試薬Aとの組み合わせ)によれば、
長期間保存後の無機リン測定値の変動は極めて少なく、
長期間安定な性能を維持していることを確認することが
できる。
(2) Stability test procedure In the above combination, 0.2 ml of each of the first reagents A to D was added to 5 μl of control serum having a known inorganic phosphorus content, and 37
Heated at 0 ° C for 5 minutes. Second reagent A 0.2 ml
Was added and reacted at 37 ° C. for 5 minutes, and the absorbance of the reaction solution at a wavelength of 600 nm was measured. at the same time,
The same operation was performed using physiological saline instead of serum, and the value at that time was used as a blank value. Separately, an aqueous solution of monopotassium phosphate (5 mg / ml) was prepared as a standard, and the same operation was performed to determine the amount of inorganic phosphorus in the control serum. Also, store each reagent at 10 ° C, and after 2 months, 4 months,
After 6 months, 9 months and 12 months, the same operation was performed using the same control serum as above, and the amount of inorganic phosphorus was determined. The standard at this time was calculated by using the absorbance measured immediately after preparation. The obtained results are shown in FIG. According to the reagent of the present invention (combination of the first reagent A to D and the second reagent A),
Very little variation in inorganic phosphorus measurement values after long-term storage,
It can be confirmed that stable performance is maintained for a long time.

【0031】比較例 比較対照用として、以下の組成からなる第一試薬aと第
二試薬aとの組み合わせa(比較例1)、及び第一試薬
bと第二試薬bとの組み合わせb(比較例2)を調製し
た。 (a)第一試薬a:50mM PIPES緩衝液(p
H6.8) XOD 16U/ml POD 10U/ml ESPT 5mM 第二試薬a:50mM PIPES緩衝液(pH6.
8) イノシン 3.7mM PNP 2U/ml 4AAP 1mM (b)第一試薬b:50mM PIPES緩衝液(p
H6.8) XOD 16U/ml POD 10U/ml ESPT 5mM イノシン 3.7mM 第二試薬b:PNP 2U/ml 4AAP 1mM 前記実施例1と同様の方法で安定性試験を実施した。結
果を図1に示す。
Comparative Example For comparison, a combination a of a first reagent a and a second reagent a (comparative example 1) and a combination b of a first reagent b and a second reagent b (comparison) having the following compositions were used. Example 2) was prepared. (A) First reagent a: 50 mM PIPES buffer (p
H6.8) XOD 16 U / ml POD 10 U / ml ESPT 5 mM Second reagent a: 50 mM PIPES buffer (pH 6.
8) Inosine 3.7 mM PNP 2U / ml 4AAP 1 mM (b) First reagent b: 50 mM PIPES buffer (p
H6.8) XOD 16U / ml POD 10U / ml ESPT 5mM Inosine 3.7mM Second reagent b: PNP 2U / ml 4AAP 1mM The stability test was carried out in the same manner as in Example 1 above. The results are shown in Fig. 1.

【0032】[0032]

【発明の効果】本発明の無機リン測定用試薬は、液状の
ままで、暗所又は明所にて、常温ないし低温下で長期間
(少なくとも1年程度)にわたって安定に貯蔵すること
ができる。従って、臨床検査を実施する現場で長期に保
存しておき、使用に際しては、溶解操作の必要もなく、
そのまま自動分析機などに適用することができる。
INDUSTRIAL APPLICABILITY The reagent for measuring inorganic phosphorus of the present invention can be stably stored in a liquid state in a dark place or a bright place at room temperature or low temperature for a long period (at least about one year). Therefore, it should be stored for a long time at the site where clinical tests are carried out, and there is no need for a lysing operation when used.
It can be applied as it is to an automatic analyzer.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明試薬及び比較用試薬を10℃で保存した
場合の安定性を示すグラフである。
FIG. 1 is a graph showing the stability of a reagent of the present invention and a reagent for comparison stored at 10 ° C.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 プリンヌクレオシドホスフォリラーゼ、
キサンチンオキシダーゼ、ペルオキシダーゼ、イノシ
ン、4−アミノアンチピリン及びN−エチル−N−スル
ホプロピル−m−トルイジンを含む無機リン測定用試薬
において、少なくともキサンチンオキシダーゼ及びプリ
ンヌクレオシドホスフォリラーゼを含有する第一試薬
と、少なくともイノシンを含有する第二試薬とからな
り、それぞれが液状試薬であることを特徴とする、無機
リン測定用試薬。
1. A purine nucleoside phosphorylase,
In a reagent for measuring inorganic phosphorus containing xanthine oxidase, peroxidase, inosine, 4-aminoantipyrine and N-ethyl-N-sulfopropyl-m-toluidine, a first reagent containing at least xanthine oxidase and purine nucleoside phosphorylase, A reagent for measuring inorganic phosphorus, comprising a second reagent containing at least inosine, each of which is a liquid reagent.
【請求項2】 第一試薬が更にN−エチル−N−スルホ
プロピル−m−トルイジンを含有する請求項1記載の無
機リン測定用試薬。
2. The reagent for measuring inorganic phosphorus according to claim 1, wherein the first reagent further contains N-ethyl-N-sulfopropyl-m-toluidine.
【請求項3】 第一試薬が更にカタラーゼを含有し、第
二試薬が更にN−エチル−N−スルホプロピル−m−ト
ルイジンを含有する請求項1記載の無機リン測定用試
薬。
3. The reagent for measuring inorganic phosphorus according to claim 1, wherein the first reagent further contains catalase and the second reagent further contains N-ethyl-N-sulfopropyl-m-toluidine.
【請求項4】 第一試薬が、更に、オキソン酸、オキソ
ン酸塩、キレート剤、金属−キレート化合物及び/又は
牛血清アルブミンを含有する請求項1〜3のいずれか一
項に記載の無機リン測定用試薬。
4. The inorganic phosphorus according to claim 1, wherein the first reagent further contains oxonic acid, oxonate, a chelating agent, a metal-chelating compound and / or bovine serum albumin. Measuring reagent.
JP35033293A 1993-12-29 1993-12-29 Inorganic phosphorus measurement reagent Expired - Lifetime JP3434553B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP35033293A JP3434553B2 (en) 1993-12-29 1993-12-29 Inorganic phosphorus measurement reagent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP35033293A JP3434553B2 (en) 1993-12-29 1993-12-29 Inorganic phosphorus measurement reagent

Publications (2)

Publication Number Publication Date
JPH07194395A true JPH07194395A (en) 1995-08-01
JP3434553B2 JP3434553B2 (en) 2003-08-11

Family

ID=18409769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP35033293A Expired - Lifetime JP3434553B2 (en) 1993-12-29 1993-12-29 Inorganic phosphorus measurement reagent

Country Status (1)

Country Link
JP (1) JP3434553B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008022862A (en) * 2007-09-28 2008-02-07 Wako Pure Chem Ind Ltd Reagent for measuring components using catalase-stabilizing agent
CN113514452A (en) * 2021-04-19 2021-10-19 深圳市锦瑞生物科技有限公司 Inorganic phosphorus detection reagent and detection chip

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008022862A (en) * 2007-09-28 2008-02-07 Wako Pure Chem Ind Ltd Reagent for measuring components using catalase-stabilizing agent
JP4640400B2 (en) * 2007-09-28 2011-03-02 和光純薬工業株式会社 Component measurement reagent using catalase stabilizer
CN113514452A (en) * 2021-04-19 2021-10-19 深圳市锦瑞生物科技有限公司 Inorganic phosphorus detection reagent and detection chip

Also Published As

Publication number Publication date
JP3434553B2 (en) 2003-08-11

Similar Documents

Publication Publication Date Title
EP0080304B1 (en) Stabilization of oxidase
US7815788B2 (en) Creatinine sensor calibration
JPS6324900A (en) Stabilized liquid enzyme composition for quantifying glucose, test kit using the same and quantifying method
US5278044A (en) Stable aqueous NADH reagent and kit
US5599661A (en) Reagent for measuring direct bilirubin
JP3434553B2 (en) Inorganic phosphorus measurement reagent
JP4639287B2 (en) Stabilization method for enzymatic measurement reagents
JP4691627B2 (en) Method for suppressing non-specific color development
US5587296A (en) Reagent for assaying glucose
EP0603831A1 (en) Stable single liquid reagent for the determination of carbon dioxide in serum
US6645735B2 (en) Reagent for GPT assay
JPH0759598A (en) Quantitative determination of sodium ion
EP0486997B1 (en) Reagent for calcium ion level determination
US7192727B2 (en) Reagent for measuring alanine aminotransferase activity
JP2880210B2 (en) Enzymatic method for colorimetric determination of conjugated bilirubin and reagents
JPH05207880A (en) Enzyme-containing composition and method for stabilizing enzyme activity
JP3159274B2 (en) Composition for measuring urea nitrogen
JP3522307B2 (en) Liquid reagent composition for measuring inorganic phosphorus
EP0607064B1 (en) Assay method and reagent for magnesium in human body fluids
EP0504380B1 (en) Method for determination of total calcium employing a diluent
JP5982608B2 (en) Reagent for measuring creatine kinase activity
JPH07115998A (en) Reagent for got determination
JPH07115997A (en) Reagent for gpt determination
JPH0937795A (en) Reagent for assaying bilirubin and assay
JPS63276500A (en) Method for determining inorganic phosphoric acid in biological humor and reagent therefor

Legal Events

Date Code Title Description
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 5

Free format text: PAYMENT UNTIL: 20080530

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 5

Free format text: PAYMENT UNTIL: 20080530

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 6

Free format text: PAYMENT UNTIL: 20090530

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100530

Year of fee payment: 7

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100530

Year of fee payment: 7

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 7

Free format text: PAYMENT UNTIL: 20100530

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 8

Free format text: PAYMENT UNTIL: 20110530

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110530

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 9

Free format text: PAYMENT UNTIL: 20120530

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120530

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130530

Year of fee payment: 10

EXPY Cancellation because of completion of term